Katie has joined the group as a PhD student having previously done her MChem project in the group. Katie is doing a Industrial Cooperative Awards in Science & Technology (CASE) PhD with Unilever. Katie’s project is titled “Controlling the delivery of benefit ingredients by tuning the microstructure of personal care products”.
Siyu has joined the group on a China Scholarship Council (CSC) award. She will be working on design nanoparticles for the delivery of actives to or through skin. Her PhD is join with Kevin Hamill in Eye & Vision Sciences.
As part of our project with Unilever, Andy McLauchlin is joining the group as a PDRA working on investigating the properties of post consumer resin.
Our long standing collaboration with the Nanomedicine Team at Liverpool has resulted in an article recently published in Nature Communications. In this paper, we highly an acceleration approach to the discover of HIV nanomedicines. We used a rapid small-scale screening method to produce large libraries of solid drug nanoparticles targeting oral dose. Through a close integration with pharmacology, we carried out iterative pharmacological and chemical evaluation to establish potential candidates for progression through to clinical manufacture. The wide applicability of our strategy has implications for multiple therapy development programmes.
See here for the full article.